Position in ONC
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$17,050,040
+$27,720 QoQ
Shares Held
59,831
+4.4% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#43
of 282 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. ONC ranks #11 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in ONC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,050,040 | 59,831 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $17,022,320 | 57,320 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,007,805 | 32,941 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $430,985 | 1,265 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $303,555 | 1,254 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $335,585 | 1,233 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $3,020,557 | 13,454 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $203,304 | 1,425 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $222,855 | 1,425 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $257,013 | 1,425 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $256,314 | 1,425 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $254,077 | 1,425 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $307,130 | 1,425 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $313,414 | 1,425 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $424,413 | 3,148 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $436,509 | 2,697 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $979,777 | 5,195 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,357,901 | 5,012 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,819,356 | 5,012 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,696,731 | 4,944 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,592,117 | 4,574 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $521,431 | 2,018 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,159,471 | 7,539 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,838,622 | 15,067 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,580,978 | 12,842 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||